A mushroom name is only the beginning of a research story. Scientists also need to know which material was tested, how it was prepared and what kind of experiment produced the result. A 2026 study of a maitake-derived compound offers a useful example.
The work concerns an isolated polysaccharide studied in mice. It does not establish a treatment benefit for people or demonstrate the effects of a commercial mushroom powder.
Meet GFP-Z: a particular molecule from maitake
In a study published online in July 2026 in Carbohydrate Polymers, researchers characterised GFP-Z, an alpha-glucan isolated from Grifola frondosa, commonly called maitake. They reported a molecular weight of approximately 1,760 kilodaltons, with an alpha-1,4-linked main chain and several types of branches. Read the study abstract.
A glucan is a chain built from glucose units. Terms such as alpha, beta and the numbered linkages describe how those units connect. These details help identify a molecule; neither the word alpha nor a large molecular weight automatically makes one preparation more useful than another.
What the researchers observed
The team tested GFP-Z in db/db mice, a model used in diabetes research. They reported lower blood glucose, changes in liver immune-cell activity and signals involving the JAK/STAT and PI3K/AKT pathways. A preliminary experiment using a pathway-blocking drug supported further investigation of an immune-related mechanism. These findings help generate hypotheses about how the preparation acts.
The paper also reported no apparent liver or kidney toxicity under its experimental conditions. That observation cannot establish long-term safety in people. Likewise, comparison with a medicine in an animal experiment cannot establish equivalent clinical effectiveness. See the original paper.
Delivery is a crucial part of the story
An accompanying research account credited to first author Wei Zhong describes a stronger glucose response when GFP-Z was injected into the abdominal cavity than when it was given orally at the same dose. It also links the pathway experiments to injected GFP-Z.
This matters when reading a headline about a mushroom ingredient. Injection and oral consumption expose the body to a substance differently. Findings from an injected preparation cannot be carried across to a powder stirred into a drink.
The word systemic also needs care. It refers to effects involving the wider body. By itself, it does not demonstrate that an intact large molecule is absorbed into the bloodstream after someone eats it.
Why different maitake studies cannot simply be pooled
A separate 2025 study in npj Science of Food examined another maitake polysaccharide preparation in mice fed a high-fat diet. The researchers characterised fractions with markedly different molecular weights and sugar compositions, and investigated glucose-related measures, gut microbes and inflammatory signalling.
The shared mushroom species does not make those preparations interchangeable. These studies ask related questions using different materials and models. Together, they illustrate why a label saying “maitake polysaccharides” is not enough to identify the substance used in a particular experiment.
Four questions to bring to the next headline
- What was tested? Look for a named, characterised preparation rather than the mushroom species alone.
- Who or what was studied? Cell experiments, mouse studies and human trials answer different questions.
- How was it administered? Check whether the material was eaten, given by a feeding tube or injected.
- What remains unknown? Look for reproducibility, human outcomes, adverse effects and whether any proposed product actually matches the research material.
GFP-Z is a subject for further investigation. The practical value of this research today is a more precise understanding of maitake chemistry and a clearer set of questions for future studies.
This article discusses research and does not recommend a product or treatment. Do not change prescribed diabetes care on the basis of a mushroom study; discuss supplement use with your healthcare professional.